OTCPK:ARUXF (Australia)  
Acrux Ltd logo

Acrux Ltd

$ 0.03 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
1.78
Market Cap:
$ 10.39M
Enterprise V:
$ 7.85M
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap $:
10.39M
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
7.85M
PB Ratio:
1.78
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. Its products include Testosterone Solution, Estradiol MDTS and others. It also has some of its products under the pipeline. Geographically, it has a presence in Australia; Germany; the United States, and other countries. The firm operates in a single segment and derives revenue from developing and commercialising pharmaceutical products which administer drugs topically. Substantial revenue comes from Australia and also earns revenue from overseas.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 2.81
Equity-to-Asset 0.64
Debt-to-Equity 0.23
Debt-to-EBITDA -0.17
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.79
Distress
Grey
Safe
Beneish M-Score -3.79
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI 0.01
14-Day RSI 0.22
6-1 Month Momentum % -62.59
12-1 Month Momentum % -64.35

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.02
Quick Ratio 3.02
Cash Ratio 1.76
Days Sales Outstanding 141.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.7

Financials

ARUXF's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ARUXF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.217
EPS (TTM) ($) -0.025
Beta 0.48
Volatility % 76.56
14-Day RSI 0.22
14-Day ATR ($) 0.000017
20-Day SMA ($) 0.0303
12-1 Month Momentum % -64.35
52-Week Range ($) 0.0303 - 0.095
Shares Outstanding (Mil) 285.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acrux Ltd Filings

Document Form Filing Date
No Filing Data

Acrux Ltd Analysis

Share your research

Headlines

See More
No news.